Revvity Inc.
USUSDRevvity Inc. (LSE:0KHE) — Biotechnology: Laboratory Analytical Instruments. Antal børser, hvor selskabets aktier handles: 3. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.
Om Virksomheden
- Websted
- revvity.com
- Sektor
- Industrials · Biotechnology: Laboratory Analytical Instruments
- Hovedkontor
- Waltham, United States
- Administrerende Direktør
- Prahlad R. Singh
- Ansatte
- 11 000
- Udestående Aktier
- 111.59 mio. pr. 2026-08-06
- Free Float
- 102.49 mio.
- Markedsværdi
- 16.63 mia. USD
- Insidere
- 0.26%
- Institutionelle Investorer
- 96.55%
- Branche (SIC)
- Laboratory Analytical Instruments
- Juridisk Form
- ZJTK
- LEI
- 549300IKL1SDPFI7N655
- Udbetalingsgrad
- 13.4%
- FCF
- 558 mio. USD6%
- Gæld
- 3.21 mia. USD3.9 år FCF
- Udbyttestreak
- 43 år
- Indtjening, FCF og udbetalt udbytte — for de 12 måneder frem til 05.07.2026 (selskabets seneste rapport).
Beskrivelse
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Udbytte
Revvity Inc. (RVTY) udbetaler udbytte kvartalsvis. Pr. År (12 måneder op til og med den senest annoncerede betaling): 0.28 USD pr. Aktie (betalinger: 4). Det svarer til cirka 0.18% af den nuværende aktiekurs. Den næste ex-udbyttedato er 23.10.2026: 0.07 USD pr. Aktie, betalt den 13.11.2026. Uafbrudt udbyttehistorik: 43 år.
| Ex-Dato | Udbetaling | Beløb | % | Type | Ticker |
|---|---|---|---|---|---|
| 2026-10-23 annonceret | 2026-11-13 | 0.0700 USD | 0.0/0.2 % | kvartalsvis | US:RVTY |
| 2026-07-17 | 2026-08-07 | 0.0700 USD | 0.0/0.2 % | kvartalsvis | US:RVTY |
| 2026-04-17 | 2026-05-08 | 0.0700 USD | 0.0/0.2 % | kvartalsvis | US:RVTY |
| 2026-01-16 | 2026-02-06 | 0.0700 USD | 0.0/0.2 % | kvartalsvis | US:RVTY |
| 2025-10-17 | 2025-11-07 | 0.0700 USD | 0.0/0.2 % | kvartalsvis | US:RVTY |
| 2025-07-18 | 2025-08-08 | 0.0700 USD | 0.0/0.2 % | kvartalsvis | US:RVTY |
| 2025-04-17 | 2025-05-09 | 0.0700 USD | 0.0/0.2 % | kvartalsvis | US:RVTY |
| 2025-01-17 | 2025-02-07 | 0.0700 USD | 0.0/≈0.2 % | kvartalsvis | US:RVTY |
| 2024-10-18 | 2024-11-08 | 0.0700 USD | 0.0/≈0.2 % | kvartalsvis | US:RVTY |
| 2024-07-19 | 2024-08-09 | 0.0700 USD | 0.0/≈0.2 % | kvartalsvis | US:RVTY |
Nyheder Denne Uge
Pressemeddelelser fra virksomhedens investorhjemmeside, opdateret dagligt. Links fører til virksomhedens hjemmeside. Overskrifterne er på originalsproget, som på virksomhedens hjemmeside.
| 06.10.2026 | Revvity to Host Investor Day |
Største Ejere
| Ejer | Andel | Aktier | Rapportdato |
|---|---|---|---|
| T. Rowe Price Investment… | 16.37% | 18.26 mio. | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 10.2% | 11.38 mio. | 2026-06-30 |
| Jupiter Topco LLC | 7.74% | 8.64 mio. | 2026-06-30 |
| Edgepoint Investment Gro… | 7.66% | 8.54 mio. | 2026-06-30 |
| Blackrock Inc. | 6.86% | 7.66 mio. | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 7.3 mio. | 2026-06-30 |
| JANUS INVESTMENT FUND-Ja… | 5.15% | 5.75 mio. | 2026-06-30 |
| Price (T.Rowe) Associate… | 4.96% | 5.53 mio. | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.28% | 4.77 mio. | 2026-06-30 |
| State Street Corporation | 3.89% | 4.34 mio. | 2026-06-30 |
| Victory Capital Manageme… | 3.27% | 3.65 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 3.55 mio. | 2026-06-30 |
| Dimensional Fund Advisor… | 3.07% | 3.43 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 2.89 mio. | 2026-06-30 |
| -Price (T.Rowe) U.S. Val… | 2.41% | 2.69 mio. | 2026-06-30 |
| TR PRICE-Price (T.Rowe)… | 2.41% | 2.69 mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 2.56 mio. | 2026-06-30 |
| JNL Series Trust-JNL/T.… | 2.27% | 2.53 mio. | 2026-06-30 |
| Victory Portfolios-Victo… | 2.12% | 2.37 mio. | 2026-06-30 |
| T. Rowe Price Value Fund… | 1.93% | 2.16 mio. | 2026-06-30 |
| Invesco Exchange-Traded… | 1.67% | 1.87 mio. | 2026-08-31 |
| SINGH PRAHLAD R (Chief E… | ≈0.09% | 105 676 | 2026-08-13 |
| GOLDBERG JOEL S (General… | ≈0.09% | 105 223 | 2026-08-14 |
| BARRETT PETER (Director) | ≈0.03% | 28 293 | 2026-05-07 |
| WITNEY FRANKLIN R. PH.D.… | ≈0.02% | 23 354 | 2026-05-07 |
| CHAPIN SAMUEL R. (Direct… | ≈0.02% | 22 676 | 2026-05-07 |
| VICTOR MIRIAME (Officer) | ≈0.02% | 18 122 | 2026-02-24 |
| WITZ PASCALE (Director) | ≈0.01% | 15 985 | 2026-05-07 |
| KRAKOWIAK MAXWELL (Chief… | ≈0.01% | 14 781 | 2026-09-21 |
| MICHAS ALEXANDROS P (Dir… | — | — | 2026-08-25 |
| MICHAS ALEXIS P (Directo… | — | — | 2025-08-27 |
